StockNews.AISignal intelligence
Company intelligence

RMTI

Rockwell Medical, Inc. · NASDAQ · Healthcare

Price$8.29+4.28% · +$0.34
Market cap32.7MEquity value
P / E-6.2Trailing ratio
Volume45.67KLatest session
Market data

RMTI price chart

TradingView
Related signals
1 min delayed

Browse public RMTI signals with their source context and measured market impact. Open any signal for its permanent analysis page.

RMTISep 15, 2024-0.65% since signal

Rockwell Medical: The Turnaround Is Looking Real

RMTI shows growth with gross margins rising to 18% in Q2 2024. Potential EBITDA growth could drive share price to $9 by 2028. CEO Mark Strobeck's arrival has stabilized RMTI after a tumultuous period. Rockwell is the largest supplier in its niche with growing market opportunities. Risks include product quality and reliance on major clients like DaVita.

View signal analysis
Research

Company intelligence